Renata Zobalová

2.3k citations
25 papers · 1.1k indexed · h-index 17
Topics
Mitochondrial Function and Pathology (8 papers)Cancer, Hypoxia, and Metabolism (7 papers)Cancer Cells and Metastasis (7 papers)

In The Last Decade

Renata Zobalová

24 papers receiving 1.1k citations

Peers

Renata Zobalová
Comparison fields: 5 of 93
  • Molecular Biology 751
  • Cancer Research 344
  • Oncology 274
  • Biochemistry 114
  • Biomedical Engineering 110
Replace Lubomír Procházka with:
Lubomír Procházka Czechia
Ruth Freeman Australia
Silvia Peppicelli Italy
Emma Swettenham Australia
Nicholas Brown United Kingdom
Jisoo Yun South Korea
Muxing Kang China
Karen Griselda de la Cruz-López Mexico
Peter Geiger United States
Nina Gellert Germany
Renata Zobalová relative to Lubomír Procházka Czechia Lubomír Procházka's profile →
Citations per field
00.5×1.5×
Lubomír Procházka · 1×
Citations per year

Countries citing papers authored by Renata Zobalová

Since Specialization
Citations

This map shows the geographic impact of Renata Zobalová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renata Zobalová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renata Zobalová more than expected).

Fields of papers citing papers by Renata Zobalová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renata Zobalová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renata Zobalová. The network helps show where Renata Zobalová may publish in the future.

Co-authorship network of co-authors of Renata Zobalová

This figure shows the co-authorship network connecting the top 25 collaborators of Renata Zobalová. A scholar is included among the top collaborators of Renata Zobalová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renata Zobalová. Renata Zobalová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 2
4 7
5 3
6 15
7 17
8 27
9 56
10 22
11 21
12 7
13 41
14 11
15 53
16 16
17 250
18 74
19 87
20 80

About Renata Zobalová

Renata Zobalová is a scholar working on Cancer Research, Biotechnology and Oncology, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (8 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Cancer Cells and Metastasis (7 papers). The work is most often cited by research in Cancer Research (344 citations), Biochemistry (114 citations) and Molecular Biology (751 citations). Renata Zobalová has collaborated with scholars based in Czechia, Australia and United States. Frequent co-authors include Jiřı́ Neužil, Lan‐Feng Dong, Marina Stantic, Stephen J. Ralph, Lubomír Procházka, Xiufang Wang, Emma Swettenham, Paul K. Witting, Ruth Freeman and Karel Vališ. Their work appears in journals such as Nature Communications, PLoS ONE and Cancer Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026